2022年癌症治疗与生存者统计
The number of cancer survivors continues to increase in the United States due to the growth and aging of the population as well as advances in early detection and treatment.…
要点
- 男性最常见三种癌症为前列腺癌、皮肤黑色素瘤和结直肠癌;女性为乳腺癌、子宫体和甲状腺癌。
- 直肠癌I期黑人患者接受直肠切除术或直肠结肠切除术的比例为41%,白人为66%。
核心结论
- 美国癌症生存者数量持续增加,但需进一步基于证据的策略和公平获取资源以减少有色人种社区的差异并优化癌症生存者照护。
研究设计与样本
- 美国癌症协会与国家癌症研究所每三年合作,利用监测、流行病学和最终结果癌症登记处的发病和生存数据、疾病控制与预防中心国家卫生统计中心的生命统计以及美国人口普查局的人口预测,估算美国癌症患病率。
主要发现
- 男性最常见三种癌症为前列腺癌(3,523,230例)、皮肤黑色素瘤(760,640例)和结直肠癌(726,450例);女性为乳腺癌(4,055,770例)、子宫体癌(891,560例)和甲状腺癌(823,800例)。
- 超过一半(53%)的生存者在过去10年内确诊,三分之二(67%)年龄在65岁或以上。
- 直肠癌I期黑人患者接受直肠切除术或直肠结肠切除术的比例为41%,白人为66%。
- 非小细胞肺癌黑人患者I-II期手术接受率为49%、III期为16%,白人分别为55%和22%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The number of cancer survivors continues to increase in the United States due to the growth and aging of the population as well as advances in early detection and treatment. To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries, vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics, and population projections from the US Census Bureau. Current treatment patterns based on information in the National Cancer Database are presented for the most prevalent cancer types by race, and cancer-related and treatment-related side-effects are also briefly described. More than 18 million Americans (8.3 million males and 9.7 million females) with a history of cancer were alive on January 1, 2022. The 3 most prevalent cancers are prostate (3,523,230), melanoma of the skin (760,640), and colon and rectum (726,450) among males and breast (4,055,770), uterine corpus (891,560), and thyroid (823,800) among females. More than one-half (53%) of survivors were diagnosed within the past 10 years, and two-thirds (67%) were aged 65 years or older. One of the largest racial disparities in treatment is for rectal cancer, for which 41% of Black patients with stage I disease receive proctectomy or proctocolectomy compared to 66% of White patients. Surgical receipt is also substantially lower among Black patients with non-small cell lung cancer, 49% for stages I-II and 16% for stage III versus 55% and 22% for White patients, respectively. These treatment disparities are exacerbated by the fact that Black patients continue to be less likely to be diagnosed with stage I disease than White patients for most cancers, with some of the largest disparities for female breast (53% vs 68%) and endometrial (59% vs 73%). Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based strategies and equitable access to available resources are needed to mitigate disparities for communities of color and optimize care for people with a history of cancer. CA Cancer J Clin. 2022;72:409-436.
引用
- Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022. PMID: 35736631. doi:10.3322/caac.21731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。